{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:37:30Z","timestamp":1790422650351,"version":"4.1.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Very early onset-inflammatory bowel disease (VEO-IBD) can arise from monogenic defects affecting immune regulation. We report a male child with VEO-IBD caused by a homozygous, loss-of-function <jats:italic>IL10RB<\/jats:italic> variant (c.562T&amp;gt;G; p.C188G) that has not been previously reported for this disorder.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Presentation<\/jats:title><jats:p>A male infant of Hispanic descent was admitted to our hospital at the age of 8 months due to intractable colitis, perianal fistulas and growth faltering. Endoscopy at nine months of life revealed pancolitis and gastritis. Despite multiple courses of steroids and use of sulfasalazine, their disease remained active. Standard biologic therapies (infliximab and adalimumab) were trialed in the second year of life without improvement. Given the very early onset and severe phenotype, functional testing by phosflow to evaluate the IL-10 signaling pathway demonstrated the absence of STAT3 phosphorylation in response to IL-10 and follow up genetic testing identified a novel homozygous <jats:italic>IL10RB<\/jats:italic> missense variant (c.562T&amp;gt;G; p.C188G). Subsequent protein structure analysis using AlphaFold corroborated this loss-of-function phenotype. The patient\u2019s condition was partially controlled with anakinra (IL-1 receptor antagonist) as a bridge therapy. At the age of 3 years, the patient underwent an allogeneic hematopoietic stem cell transplant (HSCT) from an unrelated umbilical cord blood donor; however, they experienced engraftment failure, likely due to persistent hyperinflammation and the choice of cord blood for HSCT. The patient continues to have active disease requiring on-going medical management and supportive care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We report a novel, loss-of-function <jats:italic>IL10RB<\/jats:italic> variant causing VEO-IBD, thus expanding the genotypic spectrum of this condition. This case highlights the diagnostic and therapeutic challenges of IL-10R deficiency\u2013related VEO-IBD. It also underscores the importance of early recognition of monogenic causes of IBD, use of interim immunomodulatory therapies, and the need for optimal timing and donor selection for HSCT.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1655475","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T05:21:32Z","timestamp":1759728092000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: Novel IL10RB variant causing very early onset-inflammatory bowel disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Yusuf","family":"Usman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Ptak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria C.","family":"Cohran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaruni","family":"Khanolkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz259","article-title":"Very early onset inflammatory bowel disease: A clinical approach with a focus on the role of genetics and underlying immune deficiencies","volume":"26","author":"Ouahed","year":"2020","journal-title":"Inflammation Bowel Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13302","article-title":"Understanding very early onset inflammatory bowel disease (VEOIBD) in relation to inborn errors of immunity","volume":"322","author":"Hall","year":"2024","journal-title":"Immunol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxac040","article-title":"The clinical, molecular, and therapeutic features of patients with IL10\/IL10R deficiency: a systematic review","volume":"208","author":"Sharifinejad","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.14740\/gr740w","article-title":"IL-10 and IL-10 receptor mutations in very early onset inflammatory bowel disease","volume":"10","author":"Zhu","year":"2017","journal-title":"Gastroenterol Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/B978-0-12-800267-4.00005-5","article-title":"Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans","volume":"122","author":"Shouval","year":"2014","journal-title":"Adv Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00455","article-title":"Induction of interleukin-10 producing dendritic cells as a tool to suppress allergen-specific T helper 2 responses","volume":"9","author":"Schulke","year":"2018","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312302","article-title":"Neutralizing autoantibodies against interleukin-10 in inflammatory bowel disease","volume":"391","author":"Griffin","year":"2024","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9606","DOI":"10.1038\/s41598-025-92979-6","article-title":"Treatment of IL-10RA deficiency of pediatric patients with very early onset inflammatory bowel disease by allogeneic haematopoietic stem cell transplantation","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.59","article-title":"Development and application of \u2018phosphoflow\u2019 as a tool for immunomonitoring","volume":"9","author":"Wu","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813937","article-title":"Defining the basal and immunomodulatory mediator-induced phosphoprotein signature in pediatric B cell acute lymphoblastic leukemia (B-ALL) diagnostic samples","volume":"24","author":"Khanolkar","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-022-00085-9","article-title":"Preservation of lymphocyte functional fitness in perinatally-infected and treated HIV+ pediatric patients displaying sub-optimal viral control","volume":"2","author":"Khanolkar","year":"2022","journal-title":"Commun Med (Lond)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.660520","article-title":"Evolution of our understanding of XIAP deficiency","volume":"9","author":"Mudde","year":"2021","journal-title":"Front Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jaci.2025.03.027","article-title":"Cytokine testing: Bench-ready, bedside pending","volume":"156","author":"Triaille","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2010.02.009","article-title":"Structure and mechanism of receptor sharing by the IL-10R2 common chain","volume":"18","author":"Yoon","year":"2010","journal-title":"Structure"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad1011","article-title":"AlphaFold Protein Structure Database in 2024: providing structure coverage for over 214 million protein sequences","volume":"52","author":"Varadi","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B16","first-page":"3","article-title":"Disulfide bonds in protein folding and stability","volume":"9","author":"Feige","year":"2018","journal-title":"Chem Bio"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku411","article-title":"DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach","volume":"42","author":"Pires","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.239","article-title":"Graft failure in the modern era of allogeneic hematopoietic SCT","volume":"48","author":"Olsson","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-50026-3_13","article-title":"Engraftment, graft failure, and rejection","volume-title":"The European Blood and Marrow Transplantation Textbook for Nurses: Under the Auspices of EBMT","author":"Hutt","year":"2018"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.36","article-title":"Salvage allogeneic hematopoietic SCT for primary graft failure in children","volume":"48","author":"Kato","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00068","article-title":"Improving engraftment and immune reconstitution in umbilical cord blood transplantation","volume":"5","author":"Danby","year":"2014","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1590\/1984-0462\/2022\/40\/2020434","article-title":"Elevated IgA and IL-10 levels in very-early-onset inflammatory bowel disease secondary to IL-10 receptor deficiency","volume":"40","author":"Sandy","year":"2021","journal-title":"Rev Paul Pediatr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318264","article-title":"Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling","volume":"69","author":"Koelink","year":"2020","journal-title":"Gut"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/petr.12452","article-title":"Unrelated donor hematopoietic stem cell transplantation for infantile enteropathy due to IL-10\/IL-10 receptor defect","volume":"19","author":"Gassas","year":"2015","journal-title":"Pediatr Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1089\/ped.2024.0116","article-title":"Successful use of anakinra in a patient with IL-10R beta deficiency: A case report","volume":"38","author":"Dogan","year":"2025","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clicom.2022.09.003","article-title":"Early-onset Crohn\u2019s disease, IgA nephropathy, and hemophagocytic lymphohistiocytosis in a patient with IL-10 receptor deficiency","volume":"2","author":"Khojah","year":"2022","journal-title":"Clin Immunol Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.714054","article-title":"New insights and advances in pathogenesis and treatment of very early onset inflammatory bowel disease","volume":"10","author":"Li","year":"2022","journal-title":"Front Pediatr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.26058.1","article-title":"Interleukin-6 signalling in health and disease","volume":"9","author":"Rose-John","year":"2020","journal-title":"F1000Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1655475\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T05:21:34Z","timestamp":1759728094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1655475\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2025.1655475"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1655475","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"article-number":"1655475"}}